News

Industries

Companies

Jobs

Events

People

Video

Audio

Galleries

My Biz

Submit content

My Account

Advertise

Oncology News South Africa

Can the degree of tumour angiogenesis can assessed in vivo?

Differentiation of angiogenic burden in human cancer xenografts using a perfusion type optical contrast agent (SIDAG).

With the rapid evolvement of fluorescence imaging in oncology, non-targeted fluorochromes are currently under investigation for clinical use. Here we investigated if the degree of tumour angiogenesis can be assessed in vivo by planar and tomographic methods using a perfusion-type cyanine dye (SIDAG).

Read the full document

Let's do Biz